Healthcare organisations generate enormous amounts of patient information, but converting that information into accurate medical billing remains a surprisingly manual process. Doctors document treatments, diagnoses and clinical observations in electronic health records, while specialised teams must review those records to ensure that the services billed are properly supported by the documentation. San Francisco-based Charta Health wants to automate this process using artificial intelligence. The company has raised $55 million in Series B funding led by Insight Partners, with participation from Madrona, Bain Capital Ventures, South Park Commons and QuantumLight. The financing brings Charta’s total funding to $85 million and supports its expansion from provider-focused chart review into a wider platform serving both healthcare providers and insurance companies. Its central ambition is to make medical documentation more accurate before insurance claims are submitted, rather than discovering problems after payments have already been challenged.

The medical chart is where healthcare billing accuracy begins
Every healthcare claim ultimately depends on what was documented during a patient visit. A medical chart can contain doctor’s notes, diagnosis information, laboratory results, scanned documents, treatment records and other clinical evidence. Billing teams must interpret this information and assign the appropriate medical codes before submitting a claim to an insurer. Problems arise when a documented condition is missed, a billing code lacks sufficient supporting evidence or information is recorded inconsistently. Traditional chart audits often review only a sample of patient records because examining every chart manually is expensive and time-consuming. This leaves opportunities for coding errors, payment disputes, denied claims and later financial adjustments. Charta believes large language models can now read these unstructured records at scale, allowing healthcare organisations to check far more patient encounters before billing decisions are finalised.
Charta uses AI to read clinical documents like an experienced medical coder
Charta’s platform uses large language models to analyse clinical documentation and compare it against coding guidelines, insurance requirements and organisation-specific procedures. Unlike older rules-based systems that depend heavily on predefined conditions and structured data, the platform can interpret different document types, including handwritten notes, scanned records, faxes and images. It can identify diagnoses that are documented but missing from a claim, as well as codes that appear on a claim without sufficient support in the medical record. The platform also connects its analysis to the relevant evidence so that coding specialists can understand why a particular finding was raised. Charta says it integrates with dozens of commercial and custom electronic health record systems, allowing organisations to introduce AI review without replacing their existing clinical software. It also provides dedicated engineering support to customise analysis workflows for different specialties and encounter types.
Its provider platform checks claims before they reach insurance companies
With Charta for Providers, the company is moving chart review closer to the beginning of the healthcare billing process. The platform examines patient records before claims are submitted, checks whether the documentation supports the selected codes and flags missing information or potential compliance issues. Findings are presented inside the electronic health record for human approval, allowing providers to review and correct the relevant information before billing. This matters because a coding error discovered before submission is generally easier to address than a dispute that emerges weeks or months after payment. Charta also gives clinical and revenue-cycle leaders visibility into documentation gaps, recurring errors and differences in provider performance. The company reports consistent double-digit reductions in denial rates among its fee-for-service provider customers, although these results are company-reported rather than independently audited across the market.

Charta for Payers gives insurance companies a different view of the same medical record
The Series B also supports Charta for Payers, an expanded product suite aimed initially at health plans operating in Medicare Advantage and the Affordable Care Act Marketplace. Its six AI-powered capabilities cover retrospective HCC coding, automated second-pass coding checks, a smart coding platform, prospective risk adjustment intelligence, HCC validation and audit management, and HEDIS quality-gap detection. In simple terms, the platform helps insurers identify diagnoses that are supported by clinical documentation but missing from submitted records, while also flagging diagnoses that lack sufficient evidence. This is particularly relevant to Medicare Advantage risk adjustment, where diagnosis coding helps determine the payment rates associated with members’ health conditions. Charta developed the payer offering in partnership with one of the largest US health insurers. Its broader strategy is to give providers and insurers a consistent way to interpret the same clinical record instead of allowing two separate automated systems to produce conflicting conclusions.
Enterprise customers and revenue growth are strengthening its commercial position
Charta already works with major healthcare organisations, including American Family Care, Grow Therapy and Pediatric Associates Family of Companies. The company announced that its revenue grew 10 times over the 12 months preceding its Series B announcement, reflecting demand from both healthcare providers and insurance plans. Its commercial strategy is supported by founders Justin Liu and Scott Morris, who previously worked at Rockset and brought engineering experience in data infrastructure and software systems to the company. Charta also combines this technical foundation with healthcare-specific expertise, including certified professional coding and risk-adjustment knowledge across its engineering organisation. Its distribution opportunity received another boost through an agreement with athenahealth, which made its offerings available through the athenahealth Marketplace for providers using its electronic health record and practice-management products. The new funding will support further AI development, expanded specialty coverage and the launch of its payer and provider offerings.
The next challenge is proving that AI can make healthcare billing more consistent
Charta is entering a market where accuracy is more important than simply processing documents faster. Medical coding affects reimbursements, insurance compliance, financial reporting and the administrative workload of healthcare professionals. A system that incorrectly adds diagnoses or removes valid codes could create new problems even if it significantly reduces manual work. That makes source-level evidence, human approval, clear audit trails and consistent application of coding rules essential. Charta says its platform is designed around these requirements and reports compliance with HIPAA, SOC 2 and GDPR. The company will still need to demonstrate that its results remain reliable across different specialties, insurance arrangements and increasingly complex medical records. Its challenge is not just automating chart review but establishing confidence among healthcare organisations that the technology can support important financial decisions without weakening human oversight.
Charta is betting that the future of healthcare payments starts with reading every chart
The significance of Charta Health’s $55 million Series B is the opportunity to change how medical records move through the healthcare financial system. Rather than relying on limited manual audits and resolving disagreements after claims are submitted, the company wants AI to examine documentation earlier and provide both providers and insurers with a consistent evidence-based view. If it succeeds, chart review could become a continuous layer of healthcare infrastructure connecting clinical documentation, coding, compliance and reimbursement. This would position Charta beyond a conventional medical billing software vendor and closer to an AI-powered intelligence platform for healthcare operations. Its $85 million in total funding and growing enterprise customer base give it a foundation for that ambition. The decisive test will be whether the company can scale reliable chart analysis across the healthcare industry while reducing unnecessary administrative costs and keeping qualified professionals involved in final decisions.
Sources and further reading
- Charta Health – Official $55M Series B Announcement
- Charta Health – AI Medical Chart Review Technology
- Charta Health – Products for Healthcare Providers and Payers
- MobiHealthNews – Charta’s Funding and AI Coding Products
- Fierce Healthcare – Charta’s Earlier $22M Series A
- Charta Health – Customer Case Studies
- athenahealth – Healthcare Technology Marketplace